<DOC>
	<DOCNO>NCT00559156</DOCNO>
	<brief_summary>RATIONALE : Giving nutritional supplement contain arginine , omega-3 fatty acid , nucleotide patient undergo chemotherapy radiation therapy may stimulate immune system help body build strong immune response . PURPOSE : This phase II trial study well arginine/omega-3 fatty acids/nucleotides nutritional supplement work treat patient stage III stage IV head neck cancer undergo chemotherapy radiation therapy .</brief_summary>
	<brief_title>Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement Treating Patients With Stage III Stage IV Head Neck Cancer Undergoing Chemotherapy Radiation Therapy</brief_title>
	<detailed_description>OBJECTIVES : - Assess effect immunomodulator arginine/omega-3 fatty acids/nucleotides oral supplement ( Oral IMPACT® ) administer via percutaneous gastrostomy adjuvant chemoradiotherapy patient stage III IV epidermoid head neck cancer . OUTLINE : This multicenter study . Patients undergo radiotherapy 5 day week 6½ week . Patients receive cisplatin IV week 1 , 4 , 7 radiotherapy . Patients also receive arginine/omega-3 fatty acids/nucleotides oral supplement ( Oral IMPACT® ) via percutaneous gastrostomy tube 3 time daily 5 day chemotherapy treatment .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis head neck cancer meeting follow criterion : Epidermoid carcinoma Stage III IV disease Must percutaneous gastrostomy tube place Must undergone prior surgery head neck cancer within past 68 week No cerebral metastasis PATIENT CHARACTERISTICS : WHO performance status ( PS ) 02 OR Karnofsky PS 60100 % Life expectancy &gt; 3 month WBC &gt; 4,000/mm³ ANC &gt; 2,000/mm³ Platelet count &gt; 100,000/mm³ PTT ≥ 50 % Creatinine &lt; 130 μmol/L Not pregnant nursing Fertile patient must use effective contraception No severe sepsis No requirement parenteral nutrition No preexist digestive pathology result bowel obstruction , nausea , vomit , and/or abdominal pain &gt; grade 1 PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>salivary gland squamous cell carcinoma</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
</DOC>